Weighted Average Number of Shares Outstanding, Diluted of ARTELO BIOSCIENCES, INC. from 31 Aug 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
ARTELO BIOSCIENCES, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Aug 2017 to 31 Dec 2025.
  • ARTELO BIOSCIENCES, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 343,000, a 92% increase year-over-year.
  • ARTELO BIOSCIENCES, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 343,000, a 92% increase from 2024.
  • ARTELO BIOSCIENCES, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 179,000, a 64% decline from 2023.
  • ARTELO BIOSCIENCES, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 494,000.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

ARTELO BIOSCIENCES, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 343,000 +164,000 +92% 01 Oct 2025 31 Dec 2025 8-K 17 Mar 2026
Q3 2025 787,000 +249,000 +46% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 574,000 +36,000 +6.7% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 3,281,000 +2,748,000 +516% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 179,000 01 Oct 2024 31 Dec 2024 8-K 17 Mar 2026
Q3 2024 538,000 -2,411,000 -82% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 538,000 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 533,000 01 Jan 2024 31 Mar 2024 8-K 11 Jul 2025
Q3 2023 2,949,000 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q1 2020 3,425,928 +1,508,100 +79% 01 Dec 2019 29 Feb 2020 10-Q 13 Apr 2020 2020 Q2
Q4 2019 3,379,000 +1,624,506 +93% 01 Sep 2019 30 Nov 2019 10-Q 14 Jan 2020 2020 Q1
Q3 2019 2,172,465 01 Jun 2019 31 Aug 2019 10-K/A 18 Dec 2019 2019 FY
Q2 2019 2,267,655 +675,020 +42% 01 Mar 2019 31 May 2019 10-Q 15 Jul 2019 2019 Q3
Q1 2019 1,917,828 01 Dec 2018 28 Feb 2019 10-Q 13 Apr 2020 2020 Q2
Q4 2018 1,754,494 01 Sep 2018 30 Nov 2018 10-Q 14 Jan 2020 2020 Q1
Q2 2018 1,592,635 01 Mar 2018 31 May 2018 10-Q 15 Jul 2019 2019 Q3

ARTELO BIOSCIENCES, INC. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 343,000 +164,000 +92% 01 Jan 2025 31 Dec 2025 8-K 17 Mar 2026
2024 179,000 -315,000 -64% 01 Jan 2024 31 Dec 2024 8-K 17 Mar 2026
2023 494,000 01 Jan 2023 31 Dec 2023 8-K 11 Jul 2025
2019 2,172,465 +894,938 +70% 01 Sep 2018 31 Aug 2019 10-K/A 18 Dec 2019 2019 FY
2018 1,277,527 -649,775 -34% 01 Sep 2017 31 Aug 2018 10-K/A 18 Dec 2019 2019 FY
2017 1,927,302 01 Sep 2016 31 Aug 2017 10-K 29 Nov 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.